Day: October 8, 2025
ANN ARBOR, Mich., Oct. 07, 2025 (GLOBE NEWSWIRE) — Esperion Therapeutics, Inc. (“Esperion”) (Nasdaq: ESPR), a commercial stage biopharmaceutical company that focuses on developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol (LDL-C), today announced the pricing of an underwritten public offering of 30,000,000 shares of its common stock at a public offering price of $2.50 per share. In addition, Esperion has granted the underwriters a 30-day option to purchase up to an additional 4,500,000 shares of its common stock. The gross proceeds to Esperion from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be approximately $75.0 million, excluding any exercise of the underwriters’...
Matachewan Provides Corporate Update
Written by Customer Service on . Posted in Public Companies.
TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) — Matachewan Consolidated Mines, Limited (“Matachewan” or the “Company”) (TSX-V: MCM.A-X) today announces that, from March 17, 2025 to August 7, 2025, it sold an aggregate of 91,530 common shares of Kinross Gold Corporation for aggregate consideration of $2,049,194. The Company obtained the written consent of a majority of its shareholders for the disposition, in accordance with TSXV Policy 5.3.
For further information contact: Edward G. DumondCorporate Secretary 289-231-4765Matachewan Consolidated Mines, Limited
Neither the TSX Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this news release.
Certain statements in this news release constitute “forward-looking information”...
Faraday Future Strengthens Global Leadership Team with Three New Appointments of Industry Veterans to Drive Operational Efficiency and Strategic Growth
Written by Customer Service on . Posted in Public Companies.
The new leadership appointments encompass positions in investor relations, legal and treasury roles and are key in strengthening the FF management team, implementing operational cost reductions, budgeting, governance, compliance, and strengthening FF’s treasury strategy.Faraday Future Strengthens Global Leadership Team with Three New Appointments of Industry Veterans to Drive Operational Efficiency and Strategic GrowthSteven Park joins Faraday Future as the new Head of Investor Relations.Faraday Future Strengthens Global Leadership Team with Three New Appointments of Industry Veterans to Drive Operational Efficiency and Strategic GrowthTodd Harrington joins Faraday Future as Deputy General CounselFaraday Future Strengthens Global Leadership Team with Three New Appointments of Industry Veterans to Drive Operational Efficiency...
Eloro Resources Ltd. Announces Acquisition of Shares and Warrants of Cartier Silver Corporation
Written by Customer Service on . Posted in Public Companies.
TORONTO, Oct. 07, 2025 (GLOBE NEWSWIRE) — Eloro Resources Ltd. (TSX: ELO; OTCQX: ELRRF; FSE: P2QM) (“Eloro”, or the “Company”). In accordance with regulatory requirements, the Company (the “Acquiror”) announces the acquisition of 4,800,000 units (“Units”) of Cartier Silver Corporation (the “Issuer”) on a private placement basis at a price of C$0.125 per Unit for total consideration of C$600,000. Each Unit consists of one common share (“Common Share”) and one half of one Common Share purchase warrant (each full warrant a “Warrant”) of the Issuer, with each Warrant entitling the holder to purchase one additional Common Share at a price of C$0.20 per Common Share for a period of 36 months from issuance.
Immediately prior to the acquisition of securities described above in this news release, the Acquiror owned or exercised control...